問題一覧
1
d. Stomatocytes
2
a. Codocytes
3
b. Decreases
4
ACANTHOCYTES ABETALIPOPROTEINEMIA MCLEOD PHENOMENON
5
Echinocyte (Burr cell) UREMIA PK DEFICIENCY
6
Schistocytes MICROANGIPATHIC HEMOLYTIC ANEMIA -- HUS -- TTP -- DIC -- HELLP SYNDROME MACROANGIPATHIC HEMOLYTIC ANEMIA -- WARING BLENDER SYNDROME (HEART VALVES) -- MARCH HEMOGLOBINURIA
7
Spherocytes MCHC >36% IMMUNE HEMOLYTIC ANEMIA -- HDFN -- BURNS -- HEREDITARY SPHEROCYTOSIS
8
d. Prorubricyte
9
b. F
10
Ovalocyte LARGE OVALOCYTES -- MEGALOBLASTIC ANEMIA
11
c. Complement
12
b. Howell-Jolly body
13
Elliptocyte HEREDITARY ELLIPTOCYTOSIS GERBICH NULL/ LEACH PHENOTYPE
14
Sickle cells DREPANOCYTES
15
Teardrop cells DACRYOCYTES -- MMM/ PRIMARY MYELOFIBROSIS (MYELOID METAPLASIA WITH MYELOFIBROSIS -- MYELOPTHISIC
16
a. EPO
17
Hb C crystals HEMOGLOBIN C DISEASE
18
Hb SC crystals
19
Howell-Jolly bodies
20
Basophilic stippling
21
c. 7.2 µm
22
a. Hemoglobin
23
b. Ferritin
24
b. Decreases
25
b. PNH
26
b. Apoptosis
27
d. Variation in erythrocyte shape
28
c. 3+
29
b. Abetalipoproteinemia
30
b. HDFN (Hemolytic disease of the fetus and newborn)
31
a. New methylene blue
32
d. 1:1
33
b. Hemoglobin C disease
34
a. Fragmented RBC
35
b. G6PD deficiency
36
b. Sucrose hemolysis test
37
a. HUS
38
a. SD x 100/mean
39
c. Methemoglobin reductase pathway
40
b. Very little anisocytosis
41
c. Megaloblastic anemia
42
c. Abnormal Na+/K+ permeability
43
b. myeloblast, promyelocyte, myelocyte, metamyelocyte, and band and segmented neutrophils
44
a. Promyelocyte
45
c. Lymphocytes
46
b. T lymphocyte
47
b. Glucocerebroside
48
b. Lymphocytes
49
b. ANA test
50
d. Bence Jones
51
b. At least 20%
52
b. Karyotyping
53
b. Translocation
54
b The prognosis is better if Ph1 is present
55
b. of short duration with many immature leukocyte forms in the peripheral blood
56
b. Have the ability of self-renewal by asymmetric division
57
c. M3
58
c. IL-12
59
b. Lymphocytes, mononuclear, and granulocytes
60
a. Coulter
61
c. time
62
c. Photo-optical clot detection
63
c. light amplified by stimulated emission of radiation
64
a. Hematocrit and erythrocyte distribution width
65
a. Right
66
b. Sorting of cells and cellular identification using monoclonal antibodies
67
b. Cell size and granularity
68
d. Change in movement of steel ball when clot forms
69
c. Citrate
70
d. Is used for most routine coagulation studies
71
c. The buffer was too acidic and the exposure time was too short
72
c. Within ±2 SD of the mean
73
c. compares the patient’s leukocyte and platelet counts with his or her previous results
74
b. Sodium metabisulfite
75
a. Polycythemia vera
76
b. The procedure measures the rate of erythrocyte settling.
77
d. Hematocrit
78
c. 0.5% to 1.5%
79
a. Increased
80
b. Decreased
81
a. Endomitosis
82
d. Glycocalyx
83
d. Thromboxane A2
84
b. The platelets are adhering to WBCs
85
d. All of the above
86
c. Spleen
87
a. Uremia
88
b. A reflection of the quantity and quality of platelets and other factors
89
b. platelet adhesion and aggregation on locally injured vascular subendothelium
90
a. Prekallikrein
91
b. Factor Va and VIIIa
92
c. Disseminated intravascular coagulation
93
c. Phospholipoprotein
94
c. Factor XII
95
d. Fibrinogen level
96
c. XIII
97
c. 37 degrees Celsius
98
b. PT
99
a. Normal, prolonged, normal
100
b. Normal, normal, normal
other names parasitology
other names parasitology
Yves Laure Pimentel · 70問 · 2年前other names parasitology
other names parasitology
70問 • 2年前PARASITOLOGY
PARASITOLOGY
Yves Laure Pimentel · 111問 · 2年前PARASITOLOGY
PARASITOLOGY
111問 • 2年前HTMLBE
HTMLBE
Yves Laure Pimentel · 64問 · 2年前HTMLBE
HTMLBE
64問 • 2年前CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR
CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR
Yves Laure Pimentel · 61問 · 2年前CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR
CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR
61問 • 2年前HISTOPATHOLOGY
HISTOPATHOLOGY
Yves Laure Pimentel · 69問 · 2年前HISTOPATHOLOGY
HISTOPATHOLOGY
69問 • 2年前CC-2 SPECTROPHOTOMETRY
CC-2 SPECTROPHOTOMETRY
Yves Laure Pimentel · 100問 · 2年前CC-2 SPECTROPHOTOMETRY
CC-2 SPECTROPHOTOMETRY
100問 • 2年前CC-3 ELECTROPHORESIS
CC-3 ELECTROPHORESIS
Yves Laure Pimentel · 41問 · 2年前CC-3 ELECTROPHORESIS
CC-3 ELECTROPHORESIS
41問 • 2年前AUBF LAB SAFETY
AUBF LAB SAFETY
Yves Laure Pimentel · 87問 · 2年前AUBF LAB SAFETY
AUBF LAB SAFETY
87問 • 2年前CSF 1
CSF 1
Yves Laure Pimentel · 100問 · 2年前CSF 1
CSF 1
100問 • 2年前CSF 2
CSF 2
Yves Laure Pimentel · 82問 · 2年前CSF 2
CSF 2
82問 • 2年前SEMEN 1
SEMEN 1
Yves Laure Pimentel · 100問 · 2年前SEMEN 1
SEMEN 1
100問 • 2年前SEMEN 2
SEMEN 2
Yves Laure Pimentel · 7問 · 2年前SEMEN 2
SEMEN 2
7問 • 2年前SYNOVIAL FLUID 1
SYNOVIAL FLUID 1
Yves Laure Pimentel · 100問 · 2年前SYNOVIAL FLUID 1
SYNOVIAL FLUID 1
100問 • 2年前SYNOVIAL FLUID 2
SYNOVIAL FLUID 2
Yves Laure Pimentel · 6問 · 2年前SYNOVIAL FLUID 2
SYNOVIAL FLUID 2
6問 • 2年前SEROUS FLUID
SEROUS FLUID
Yves Laure Pimentel · 25問 · 2年前SEROUS FLUID
SEROUS FLUID
25問 • 2年前PLEURAL FLUID
PLEURAL FLUID
Yves Laure Pimentel · 44問 · 2年前PLEURAL FLUID
PLEURAL FLUID
44問 • 2年前PERICARDIAL FLUID
PERICARDIAL FLUID
Yves Laure Pimentel · 18問 · 2年前PERICARDIAL FLUID
PERICARDIAL FLUID
18問 • 2年前PERITONEAL FLUID/ ASCITIC FLUID
PERITONEAL FLUID/ ASCITIC FLUID
Yves Laure Pimentel · 30問 · 2年前PERITONEAL FLUID/ ASCITIC FLUID
PERITONEAL FLUID/ ASCITIC FLUID
30問 • 2年前AMNIOTIC FLUID
AMNIOTIC FLUID
Yves Laure Pimentel · 92問 · 2年前AMNIOTIC FLUID
AMNIOTIC FLUID
92問 • 2年前FECALYSIS
FECALYSIS
Yves Laure Pimentel · 80問 · 2年前FECALYSIS
FECALYSIS
80問 • 2年前問題一覧
1
d. Stomatocytes
2
a. Codocytes
3
b. Decreases
4
ACANTHOCYTES ABETALIPOPROTEINEMIA MCLEOD PHENOMENON
5
Echinocyte (Burr cell) UREMIA PK DEFICIENCY
6
Schistocytes MICROANGIPATHIC HEMOLYTIC ANEMIA -- HUS -- TTP -- DIC -- HELLP SYNDROME MACROANGIPATHIC HEMOLYTIC ANEMIA -- WARING BLENDER SYNDROME (HEART VALVES) -- MARCH HEMOGLOBINURIA
7
Spherocytes MCHC >36% IMMUNE HEMOLYTIC ANEMIA -- HDFN -- BURNS -- HEREDITARY SPHEROCYTOSIS
8
d. Prorubricyte
9
b. F
10
Ovalocyte LARGE OVALOCYTES -- MEGALOBLASTIC ANEMIA
11
c. Complement
12
b. Howell-Jolly body
13
Elliptocyte HEREDITARY ELLIPTOCYTOSIS GERBICH NULL/ LEACH PHENOTYPE
14
Sickle cells DREPANOCYTES
15
Teardrop cells DACRYOCYTES -- MMM/ PRIMARY MYELOFIBROSIS (MYELOID METAPLASIA WITH MYELOFIBROSIS -- MYELOPTHISIC
16
a. EPO
17
Hb C crystals HEMOGLOBIN C DISEASE
18
Hb SC crystals
19
Howell-Jolly bodies
20
Basophilic stippling
21
c. 7.2 µm
22
a. Hemoglobin
23
b. Ferritin
24
b. Decreases
25
b. PNH
26
b. Apoptosis
27
d. Variation in erythrocyte shape
28
c. 3+
29
b. Abetalipoproteinemia
30
b. HDFN (Hemolytic disease of the fetus and newborn)
31
a. New methylene blue
32
d. 1:1
33
b. Hemoglobin C disease
34
a. Fragmented RBC
35
b. G6PD deficiency
36
b. Sucrose hemolysis test
37
a. HUS
38
a. SD x 100/mean
39
c. Methemoglobin reductase pathway
40
b. Very little anisocytosis
41
c. Megaloblastic anemia
42
c. Abnormal Na+/K+ permeability
43
b. myeloblast, promyelocyte, myelocyte, metamyelocyte, and band and segmented neutrophils
44
a. Promyelocyte
45
c. Lymphocytes
46
b. T lymphocyte
47
b. Glucocerebroside
48
b. Lymphocytes
49
b. ANA test
50
d. Bence Jones
51
b. At least 20%
52
b. Karyotyping
53
b. Translocation
54
b The prognosis is better if Ph1 is present
55
b. of short duration with many immature leukocyte forms in the peripheral blood
56
b. Have the ability of self-renewal by asymmetric division
57
c. M3
58
c. IL-12
59
b. Lymphocytes, mononuclear, and granulocytes
60
a. Coulter
61
c. time
62
c. Photo-optical clot detection
63
c. light amplified by stimulated emission of radiation
64
a. Hematocrit and erythrocyte distribution width
65
a. Right
66
b. Sorting of cells and cellular identification using monoclonal antibodies
67
b. Cell size and granularity
68
d. Change in movement of steel ball when clot forms
69
c. Citrate
70
d. Is used for most routine coagulation studies
71
c. The buffer was too acidic and the exposure time was too short
72
c. Within ±2 SD of the mean
73
c. compares the patient’s leukocyte and platelet counts with his or her previous results
74
b. Sodium metabisulfite
75
a. Polycythemia vera
76
b. The procedure measures the rate of erythrocyte settling.
77
d. Hematocrit
78
c. 0.5% to 1.5%
79
a. Increased
80
b. Decreased
81
a. Endomitosis
82
d. Glycocalyx
83
d. Thromboxane A2
84
b. The platelets are adhering to WBCs
85
d. All of the above
86
c. Spleen
87
a. Uremia
88
b. A reflection of the quantity and quality of platelets and other factors
89
b. platelet adhesion and aggregation on locally injured vascular subendothelium
90
a. Prekallikrein
91
b. Factor Va and VIIIa
92
c. Disseminated intravascular coagulation
93
c. Phospholipoprotein
94
c. Factor XII
95
d. Fibrinogen level
96
c. XIII
97
c. 37 degrees Celsius
98
b. PT
99
a. Normal, prolonged, normal
100
b. Normal, normal, normal